Brief: Quantum Genomics Receives First Regulatory And Ethics Approvals To Initiate Phase IIb Quorum Study Of Firibastat In Heart Failure
17/04/2019 17:14
April 17 (Reuters) - QUANTUM GENOMICS SA ALQGC.PA :
* QUANTUM GENOMICS SA - QUANTUM GENOMICS RECEIVES FIRST
REGULATORY
AND ETHICS APPROVALS TO INITIATE PHASE IIB QUORUM STUDY OF
FIRIBASTAT IN HEART FAILURE
Source text for Eikon: ID:nNDL44rz9q
Further company coverage: ALQGC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study